activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470416	CHEMBL981798	Inhibition of TNK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5334	Homo sapiens	INH	%	10.0
	2470416	CHEMBL981798	Inhibition of TNK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5334	Homo sapiens	INH	%	10.0
	2476649	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	16.7	CHEMBL5334	Homo sapiens	Activity	%	16.7
	2476852	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582	=	Activity	%	25.9	CHEMBL5334	Homo sapiens	Activity	%	25.9
Not Evaluated	2478691	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5334	Homo sapiens	Activity		
	2479527	CHEMBL988921	Binding affinity to human TNK1	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	85.0	CHEMBL5334	Homo sapiens	Kd	nM	85.0
Not Evaluated	2479749	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5334	Homo sapiens	Activity		
Not Evaluated	2480546	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5334	Homo sapiens	Activity		
	2480748	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	1.0	CHEMBL5334	Homo sapiens	Activity	%	1.0
Not Evaluated	2577370	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5334	Homo sapiens	Activity		
Active	2593575	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5334	Homo sapiens	Activity		
	2593778	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	19.9	CHEMBL5334	Homo sapiens	Activity	%	19.9
Not Evaluated	2593841	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5334	Homo sapiens	Activity		
Not Evaluated	2594044	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5334	Homo sapiens	Activity		
Not Evaluated	2594987	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5334	Homo sapiens	Activity		
Not Evaluated	2595256	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5334	Homo sapiens	Activity		
	2595789	CHEMBL1017051	Binding affinity to Tnk1	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	640.0	CHEMBL5334	Homo sapiens	Kd	nM	640.0
Not Evaluated	2596184	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5334	Homo sapiens	Activity		
	2596387	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	6.1	CHEMBL5334	Homo sapiens	Activity	%	6.1
	2596923	CHEMBL1021460	Inhibition of TNK1 assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	12.0	CHEMBL5334	Homo sapiens	Activity	%	12.0
Not Evaluated	2597656	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5334	Homo sapiens	Activity		
Not Evaluated	2597859	CHEMBL1024901	Binding affinity to human TNK1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5334	Homo sapiens	Activity		
	2896679	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896680	CHEMBL1062788	Binding constant for full-length TNK1	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896681	CHEMBL1062788	Binding constant for full-length TNK1	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	60.0	CHEMBL5334	Homo sapiens	Kd	nM	60.0
	2896682	CHEMBL1062788	Binding constant for full-length TNK1	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896683	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896684	CHEMBL1062788	Binding constant for full-length TNK1	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896685	CHEMBL1062788	Binding constant for full-length TNK1	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896686	CHEMBL1062788	Binding constant for full-length TNK1	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896687	CHEMBL1062788	Binding constant for full-length TNK1	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896688	CHEMBL1062788	Binding constant for full-length TNK1	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	640.0	CHEMBL5334	Homo sapiens	Kd	nM	640.0
	2896689	CHEMBL1062788	Binding constant for full-length TNK1	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896690	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896691	CHEMBL1062788	Binding constant for full-length TNK1	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896692	CHEMBL1062788	Binding constant for full-length TNK1	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	630.0	CHEMBL5334	Homo sapiens	Kd	nM	630.0
	2896693	CHEMBL1062788	Binding constant for full-length TNK1	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896694	CHEMBL1062788	Binding constant for full-length TNK1	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896695	CHEMBL1062788	Binding constant for full-length TNK1	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896696	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	980.0	CHEMBL5334	Homo sapiens	Kd	nM	980.0
	2896697	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896698	CHEMBL1062788	Binding constant for full-length TNK1	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896699	CHEMBL1062788	Binding constant for full-length TNK1	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896700	CHEMBL1062788	Binding constant for full-length TNK1	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896701	CHEMBL1062788	Binding constant for full-length TNK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896702	CHEMBL1062788	Binding constant for full-length TNK1	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2400.0	CHEMBL5334	Homo sapiens	Kd	nM	2400.0
	2896703	CHEMBL1062788	Binding constant for full-length TNK1	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896704	CHEMBL1062788	Binding constant for full-length TNK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	83.0	CHEMBL5334	Homo sapiens	Kd	nM	83.0
	2896705	CHEMBL1062788	Binding constant for full-length TNK1	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896706	CHEMBL1062788	Binding constant for full-length TNK1	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896707	CHEMBL1062788	Binding constant for full-length TNK1	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896708	CHEMBL1062788	Binding constant for full-length TNK1	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896709	CHEMBL1062788	Binding constant for full-length TNK1	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896710	CHEMBL1062788	Binding constant for full-length TNK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2300.0	CHEMBL5334	Homo sapiens	Kd	nM	2300.0
	2896711	CHEMBL1062788	Binding constant for full-length TNK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2.5	CHEMBL5334	Homo sapiens	Kd	nM	2.5
	2896712	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1500.0	CHEMBL5334	Homo sapiens	Kd	nM	1500.0
	2896713	CHEMBL1062788	Binding constant for full-length TNK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	680.0	CHEMBL5334	Homo sapiens	Kd	nM	680.0
	2896714	CHEMBL1062788	Binding constant for full-length TNK1	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	83.0	CHEMBL5334	Homo sapiens	Kd	nM	83.0
	2896715	CHEMBL1062788	Binding constant for full-length TNK1	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2896716	CHEMBL1062788	Binding constant for full-length TNK1	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	2922023	CHEMBL1059382	Inhibition of TNK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5334	Homo sapiens	Activity	%	100.0
	3213861	CHEMBL1111277	Inhibition of TNK1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	9.0	CHEMBL5334	Homo sapiens	INH	%	9.0
	3333194	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	58.25	CHEMBL5334	Homo sapiens	INH	%	58.25
	3334599	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3335001	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3336421	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3337665	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3338996	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3339252	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3340557	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	81.7	CHEMBL5334	Homo sapiens	INH	%	81.7
	3341963	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3343410	CHEMBL1168133	Inhibition of TNK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	3351787	CHEMBL1175101	Inhibition of TNK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.8	CHEMBL5334	Homo sapiens	INH	%	0.8
	3358839	CHEMBL1175101	Inhibition of TNK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL5334	Homo sapiens	INH	%	0.0
	3448654	CHEMBL1245007	Binding affinity to TNK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	3448811	CHEMBL1245007	Binding affinity to TNK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	9.3	CHEMBL5334	Homo sapiens	Kd	nM	9.3
	3449063	CHEMBL1245007	Binding affinity to TNK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	83.0	CHEMBL5334	Homo sapiens	Kd	nM	83.0
	3449365	CHEMBL1245007	Binding affinity to TNK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	570.0	CHEMBL5334	Homo sapiens	Kd	nM	570.0
	3449366	CHEMBL1245007	Binding affinity to TNK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	680.0	CHEMBL5334	Homo sapiens	Kd	nM	680.0
	3449522	CHEMBL1245007	Binding affinity to TNK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2300.0	CHEMBL5334	Homo sapiens	Kd	nM	2300.0
	3449879	CHEMBL1245007	Binding affinity to TNK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	uM	10.0
	5123823	CHEMBL1645767	Inhibition of TNK1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	99.0	CHEMBL5334	Homo sapiens	INH	%	99.0
	5223293	CHEMBL1679285	Binding affinity to TNK1 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Inhibition	%	90.0	CHEMBL5334	Homo sapiens	INH	%	90.0
	5223294	CHEMBL1679285	Binding affinity to TNK1 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL5334	Homo sapiens	INH	%	90.0
	5223309	CHEMBL1679299	Binding affinity to TNK1 by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	Kd	nM	29.0	CHEMBL5334	Homo sapiens	Kd	nM	29.0
	6341139	CHEMBL1826996	Activity of TNK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5334	Homo sapiens	Activity	%	100.0
	7567328	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7567787	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	120.0	CHEMBL5334	Homo sapiens	Kd	nM	120.0
	7568284	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	360.0	CHEMBL5334	Homo sapiens	Kd	nM	360.0
	7568716	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1500.0	CHEMBL5334	Homo sapiens	Kd	nM	1500.0
	7569301	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7569761	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	320.0	CHEMBL5334	Homo sapiens	Kd	nM	320.0
	7569791	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7570254	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7570681	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	680.0	CHEMBL5334	Homo sapiens	Kd	nM	680.0
	7571277	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7571768	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7572231	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7572647	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1.8	CHEMBL5334	Homo sapiens	Kd	nM	1.8
	7573273	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7573749	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2200.0	CHEMBL5334	Homo sapiens	Kd	nM	2200.0
	7574218	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	83.0	CHEMBL5334	Homo sapiens	Kd	nM	83.0
	7574626	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7574794	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	210.0	CHEMBL5334	Homo sapiens	Kd	nM	210.0
	7575255	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	630.0	CHEMBL5334	Homo sapiens	Kd	nM	630.0
	7575726	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7576191	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7576599	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	360.0	CHEMBL5334	Homo sapiens	Kd	nM	360.0
	7576768	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7577227	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	21.0	CHEMBL5334	Homo sapiens	Kd	nM	21.0
	7577705	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	580.0	CHEMBL5334	Homo sapiens	Kd	nM	580.0
	7578175	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1200.0	CHEMBL5334	Homo sapiens	Kd	nM	1200.0
	7578580	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7578776	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7579150	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7579600	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7580074	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7581134	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7581519	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7581964	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7582435	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	3400.0	CHEMBL5334	Homo sapiens	Kd	nM	3400.0
	7582457	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7582857	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	83.0	CHEMBL5334	Homo sapiens	Kd	nM	83.0
	7583480	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7583877	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7584322	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7584813	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	25.0	CHEMBL5334	Homo sapiens	Kd	nM	25.0
	7585217	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7585810	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7586218	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7586693	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7587147	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7587771	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	160.0	CHEMBL5334	Homo sapiens	Kd	nM	160.0
	7588201	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7588672	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7589123	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7589718	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	9.3	CHEMBL5334	Homo sapiens	Kd	nM	9.3
	7590185	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	1500.0	CHEMBL5334	Homo sapiens	Kd	nM	1500.0
	7590659	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7591110	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7591267	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7591689	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7592161	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7592634	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2400.0	CHEMBL5334	Homo sapiens	Kd	nM	2400.0
	7593087	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7593234	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	60.0	CHEMBL5334	Homo sapiens	Kd	nM	60.0
	7593669	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	6400.0	CHEMBL5334	Homo sapiens	Kd	nM	6400.0
	7594141	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7594614	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7595066	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2300.0	CHEMBL5334	Homo sapiens	Kd	nM	2300.0
	7595202	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7595646	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7596120	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7596591	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7597174	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7597627	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7598100	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5334	Homo sapiens	Kd	nM	10000.0
	7598570	CHEMBL1908627	Binding constant for TNK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2.5	CHEMBL5334	Homo sapiens	Kd	nM	2.5
	7996732	CHEMBL1944384	Inhibition of TNK1 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	98.0	CHEMBL5334	Homo sapiens	INH	%	98.0
	7996765	CHEMBL1944384	Inhibition of TNK1 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	97.0	CHEMBL5334	Homo sapiens	INH	%	97.0
	8061379	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%		CHEMBL5334	Homo sapiens	Inhibition	%	
	8061603	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.22	CHEMBL5334	Homo sapiens	Inhibition	%	-2.22
	8061710	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.22	CHEMBL5334	Homo sapiens	Inhibition	%	-0.22
	8062125	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.27	CHEMBL5334	Homo sapiens	Inhibition	%	4.27
	8062241	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	14.67	CHEMBL5334	Homo sapiens	Inhibition	%	14.67
	8062465	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.08	CHEMBL5334	Homo sapiens	Inhibition	%	1.08
	8062627	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.51	CHEMBL5334	Homo sapiens	Inhibition	%	6.51
	8062949	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-5.95	CHEMBL5334	Homo sapiens	Inhibition	%	-5.95
	8063081	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.81	CHEMBL5334	Homo sapiens	Inhibition	%	-1.81
	8063472	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.89	CHEMBL5334	Homo sapiens	Inhibition	%	0.89
	8063580	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.4	CHEMBL5334	Homo sapiens	Inhibition	%	7.4
	8063804	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.36	CHEMBL5334	Homo sapiens	Inhibition	%	1.36
	8063986	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.9	CHEMBL5334	Homo sapiens	Inhibition	%	9.9
	8064325	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.76	CHEMBL5334	Homo sapiens	Inhibition	%	0.76
	8064535	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.44	CHEMBL5334	Homo sapiens	Inhibition	%	0.44
	8064673	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.42	CHEMBL5334	Homo sapiens	Inhibition	%	1.42
	8064897	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.16	CHEMBL5334	Homo sapiens	Inhibition	%	5.16
	8065063	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	13.29	CHEMBL5334	Homo sapiens	Inhibition	%	13.29
	8065403	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.98	CHEMBL5334	Homo sapiens	Inhibition	%	-0.98
	8065578	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.44	CHEMBL5334	Homo sapiens	Inhibition	%	1.44
	8065917	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.05	CHEMBL5334	Homo sapiens	Inhibition	%	6.05
	8066127	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	8.64	CHEMBL5334	Homo sapiens	Inhibition	%	8.64
	8066487	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	26.75	CHEMBL5334	Homo sapiens	Inhibition	%	26.75
	8066653	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.34	CHEMBL5334	Homo sapiens	Inhibition	%	1.34
	8067001	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.04	CHEMBL5334	Homo sapiens	Inhibition	%	3.04
	8067176	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.7	CHEMBL5334	Homo sapiens	Inhibition	%	5.7
	8067400	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.2	CHEMBL5334	Homo sapiens	Inhibition	%	-0.2
	8067521	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.93	CHEMBL5334	Homo sapiens	Inhibition	%	6.93
	8067731	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.71	CHEMBL5334	Homo sapiens	Inhibition	%	0.71
	8067955	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-5.44	CHEMBL5334	Homo sapiens	Inhibition	%	-5.44
	8068090	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	26.79	CHEMBL5334	Homo sapiens	Inhibition	%	26.79
	8068254	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	11.96	CHEMBL5334	Homo sapiens	Inhibition	%	11.96
	8068478	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.36	CHEMBL5334	Homo sapiens	Inhibition	%	2.36
	8068603	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	8.8	CHEMBL5334	Homo sapiens	Inhibition	%	8.8
	8069001	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-6.28	CHEMBL5334	Homo sapiens	Inhibition	%	-6.28
	8069126	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.64	CHEMBL5334	Homo sapiens	Inhibition	%	-0.64
	8069421	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	64.41	CHEMBL5334	Homo sapiens	Inhibition	%	64.41
	8069806	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	15.41	CHEMBL5334	Homo sapiens	Inhibition	%	15.41
	8069932	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.86	CHEMBL5334	Homo sapiens	Inhibition	%	-1.86
	8070156	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.53	CHEMBL5334	Homo sapiens	Inhibition	%	2.53
	8070328	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.52	CHEMBL5334	Homo sapiens	Inhibition	%	4.52
	8070453	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.91	CHEMBL5334	Homo sapiens	Inhibition	%	0.91
	8070677	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.85	CHEMBL5334	Homo sapiens	Inhibition	%	0.85
	8070751	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	18.51	CHEMBL5334	Homo sapiens	Inhibition	%	18.51
	8070975	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	64.37	CHEMBL5334	Homo sapiens	Inhibition	%	64.37
	8071132	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.6	CHEMBL5334	Homo sapiens	Inhibition	%	-0.6
	8071482	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.63	CHEMBL5334	Homo sapiens	Inhibition	%	-0.63
	8071655	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.26	CHEMBL5334	Homo sapiens	Inhibition	%	8.26
	8072004	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.32	CHEMBL5334	Homo sapiens	Inhibition	%	-0.32
	8072318	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.45	CHEMBL5334	Homo sapiens	Inhibition	%	-0.45
	8072475	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.55	CHEMBL5334	Homo sapiens	Inhibition	%	7.55
	8072824	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.33	CHEMBL5334	Homo sapiens	Inhibition	%	0.33
	8072991	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.22	CHEMBL5334	Homo sapiens	Inhibition	%	2.22
	8073340	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	11.51	CHEMBL5334	Homo sapiens	Inhibition	%	11.51
	8073683	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-2.23	CHEMBL5334	Homo sapiens	Inhibition	%	-2.23
	8073916	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-3.58	CHEMBL5334	Homo sapiens	Inhibition	%	-3.58
	8074068	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.64	CHEMBL5334	Homo sapiens	Inhibition	%	2.64
	8074292	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.12	CHEMBL5334	Homo sapiens	Inhibition	%	4.12
	8074422	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	8.67	CHEMBL5334	Homo sapiens	Inhibition	%	8.67
	8074579	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.4	CHEMBL5334	Homo sapiens	Inhibition	%	-0.4
	8074803	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.61	CHEMBL5334	Homo sapiens	Inhibition	%	-0.61
	8074930	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	27.19	CHEMBL5334	Homo sapiens	Inhibition	%	27.19
	8075265	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.63	CHEMBL5334	Homo sapiens	Inhibition	%	3.63
	8075502	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.12	CHEMBL5334	Homo sapiens	Inhibition	%	-0.12
	8075867	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.16	CHEMBL5334	Homo sapiens	Inhibition	%	0.16
	8076009	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	48.68	CHEMBL5334	Homo sapiens	Inhibition	%	48.68
	8076381	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-3.16	CHEMBL5334	Homo sapiens	Inhibition	%	-3.16
	8076515	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.11	CHEMBL5334	Homo sapiens	Inhibition	%	0.11
	8076739	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	22.32	CHEMBL5334	Homo sapiens	Inhibition	%	22.32
	8076841	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.29	CHEMBL5334	Homo sapiens	Inhibition	%	0.29
	8077088	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-4.05	CHEMBL5334	Homo sapiens	Inhibition	%	-4.05
	8077440	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	10.96	CHEMBL5334	Homo sapiens	Inhibition	%	10.96
	8077591	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.54	CHEMBL5334	Homo sapiens	Inhibition	%	1.54
	8077815	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	19.82	CHEMBL5334	Homo sapiens	Inhibition	%	19.82
	8077958	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.85	CHEMBL5334	Homo sapiens	Inhibition	%	2.85
	8078321	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-4.31	CHEMBL5334	Homo sapiens	Inhibition	%	-4.31
	8078423	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-6.97	CHEMBL5334	Homo sapiens	Inhibition	%	-6.97
	8078647	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-4.28	CHEMBL5334	Homo sapiens	Inhibition	%	-4.28
	8078673	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-3.17	CHEMBL5334	Homo sapiens	Inhibition	%	-3.17
	8078897	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-3.26	CHEMBL5334	Homo sapiens	Inhibition	%	-3.26
	8079013	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.4	CHEMBL5334	Homo sapiens	Inhibition	%	-0.4
	8079395	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.47	CHEMBL5334	Homo sapiens	Inhibition	%	-0.47
	8079537	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	13.48	CHEMBL5334	Homo sapiens	Inhibition	%	13.48
	8079900	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	24.29	CHEMBL5334	Homo sapiens	Inhibition	%	24.29
	8080229	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-5.17	CHEMBL5334	Homo sapiens	Inhibition	%	-5.17
	8080481	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.82	CHEMBL5334	Homo sapiens	Inhibition	%	-3.82
	8080596	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.43	CHEMBL5334	Homo sapiens	Inhibition	%	5.43
	8080820	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.34	CHEMBL5334	Homo sapiens	Inhibition	%	2.34
	8080984	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	18.25	CHEMBL5334	Homo sapiens	Inhibition	%	18.25
	8081119	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.61	CHEMBL5334	Homo sapiens	Inhibition	%	0.61
	8081343	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	7.01	CHEMBL5334	Homo sapiens	Inhibition	%	7.01
	8081487	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	46.44	CHEMBL5334	Homo sapiens	Inhibition	%	46.44
	8081814	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.52	CHEMBL5334	Homo sapiens	Inhibition	%	0.52
	8082066	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	5.07	CHEMBL5334	Homo sapiens	Inhibition	%	5.07
	8082403	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	12.34	CHEMBL5334	Homo sapiens	Inhibition	%	12.34
	8082576	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-6.18	CHEMBL5334	Homo sapiens	Inhibition	%	-6.18
	8082923	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.31	CHEMBL5334	Homo sapiens	Inhibition	%	-0.31
	8083079	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	92.81	CHEMBL5334	Homo sapiens	Inhibition	%	92.81
	8083402	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.8	CHEMBL5334	Homo sapiens	Inhibition	%	8.8
	8083656	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.33	CHEMBL5334	Homo sapiens	Inhibition	%	-1.33
	8083990	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.5	CHEMBL5334	Homo sapiens	Inhibition	%	1.5
	8084175	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.86	CHEMBL5334	Homo sapiens	Inhibition	%	-2.86
	8084517	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-1.43	CHEMBL5334	Homo sapiens	Inhibition	%	-1.43
	8084678	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.1	CHEMBL5334	Homo sapiens	Inhibition	%	6.1
	8084902	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	16.47	CHEMBL5334	Homo sapiens	Inhibition	%	16.47
	8085000	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.45	CHEMBL5334	Homo sapiens	Inhibition	%	2.45
	8085256	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	20.8	CHEMBL5334	Homo sapiens	Inhibition	%	20.8
	8085588	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	8.96	CHEMBL5334	Homo sapiens	Inhibition	%	8.96
	8085777	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	14.55	CHEMBL5334	Homo sapiens	Inhibition	%	14.55
	8086001	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	56.79	CHEMBL5334	Homo sapiens	Inhibition	%	56.79
	8086116	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.66	CHEMBL5334	Homo sapiens	Inhibition	%	3.66
	8086502	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.57	CHEMBL5334	Homo sapiens	Inhibition	%	3.57
	8086601	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-6.75	CHEMBL5334	Homo sapiens	Inhibition	%	-6.75
	8086825	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.44	CHEMBL5334	Homo sapiens	Inhibition	%	3.44
	8087036	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	8.81	CHEMBL5334	Homo sapiens	Inhibition	%	8.81
	8087194	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.74	CHEMBL5334	Homo sapiens	Inhibition	%	9.74
	8087532	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	82.45	CHEMBL5334	Homo sapiens	Inhibition	%	82.45
	8087894	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	18.46	CHEMBL5334	Homo sapiens	Inhibition	%	18.46
	8088036	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.89	CHEMBL5334	Homo sapiens	Inhibition	%	3.89
	8088408	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.13	CHEMBL5334	Homo sapiens	Inhibition	%	1.13
	8088536	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.48	CHEMBL5334	Homo sapiens	Inhibition	%	8.48
	8088760	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	33.8	CHEMBL5334	Homo sapiens	Inhibition	%	33.8
	8088853	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.77	CHEMBL5334	Homo sapiens	Inhibition	%	2.77
	8089205	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-2.66	CHEMBL5334	Homo sapiens	Inhibition	%	-2.66
	8089353	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	10.84	CHEMBL5334	Homo sapiens	Inhibition	%	10.84
	8089577	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	9.88	CHEMBL5334	Homo sapiens	Inhibition	%	9.88
	8089697	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.14	CHEMBL5334	Homo sapiens	Inhibition	%	5.14
	8089877	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.37	CHEMBL5334	Homo sapiens	Inhibition	%	2.37
	8090101	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.22	CHEMBL5334	Homo sapiens	Inhibition	%	-0.22
	8090266	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.48	CHEMBL5334	Homo sapiens	Inhibition	%	3.48
	8090433	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.48	CHEMBL5334	Homo sapiens	Inhibition	%	5.48
	8090657	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.98	CHEMBL5334	Homo sapiens	Inhibition	%	1.98
	8090796	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	14.7	CHEMBL5334	Homo sapiens	Inhibition	%	14.7
	8091001	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	9.47	CHEMBL5334	Homo sapiens	Inhibition	%	9.47
	8091225	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.51	CHEMBL5334	Homo sapiens	Inhibition	%	3.51
	8091362	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	38.75	CHEMBL5334	Homo sapiens	Inhibition	%	38.75
	8091517	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.12	CHEMBL5334	Homo sapiens	Inhibition	%	-0.12
	8091741	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.35	CHEMBL5334	Homo sapiens	Inhibition	%	6.35
	8091857	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.82	CHEMBL5334	Homo sapiens	Inhibition	%	3.82
	8092218	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.27	CHEMBL5334	Homo sapiens	Inhibition	%	0.27
	8092369	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.69	CHEMBL5334	Homo sapiens	Inhibition	%	5.69
	8092593	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.8	CHEMBL5334	Homo sapiens	Inhibition	%	1.8
	8092741	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	5.5	CHEMBL5334	Homo sapiens	Inhibition	%	5.5
	8093094	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	79.53	CHEMBL5334	Homo sapiens	Inhibition	%	79.53
	8093182	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.19	CHEMBL5334	Homo sapiens	Inhibition	%	4.19
	8093406	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.14	CHEMBL5334	Homo sapiens	Inhibition	%	0.14
	8093546	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.46	CHEMBL5334	Homo sapiens	Inhibition	%	1.46
	8093909	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	65.63	CHEMBL5334	Homo sapiens	Inhibition	%	65.63
	8094029	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	16.85	CHEMBL5334	Homo sapiens	Inhibition	%	16.85
	8094433	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	14.25	CHEMBL5334	Homo sapiens	Inhibition	%	14.25
	8094608	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	22.44	CHEMBL5334	Homo sapiens	Inhibition	%	22.44
	8094988	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.53	CHEMBL5334	Homo sapiens	Inhibition	%	2.53
	8095128	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	21.36	CHEMBL5334	Homo sapiens	Inhibition	%	21.36
	8095555	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	16.62	CHEMBL5334	Homo sapiens	Inhibition	%	16.62
	8095696	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	26.39	CHEMBL5334	Homo sapiens	Inhibition	%	26.39
	8096068	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.1	CHEMBL5334	Homo sapiens	Inhibition	%	7.1
	8096185	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	13.83	CHEMBL5334	Homo sapiens	Inhibition	%	13.83
	8096409	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.98	CHEMBL5334	Homo sapiens	Inhibition	%	3.98
	8096548	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.01	CHEMBL5334	Homo sapiens	Inhibition	%	1.01
	8096928	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.39	CHEMBL5334	Homo sapiens	Inhibition	%	6.39
	8097075	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.5	CHEMBL5334	Homo sapiens	Inhibition	%	3.5
	8097386	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	24.12	CHEMBL5334	Homo sapiens	Inhibition	%	24.12
	8097606	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.92	CHEMBL5334	Homo sapiens	Inhibition	%	3.92
	8097756	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.6	CHEMBL5334	Homo sapiens	Inhibition	%	-2.6
	8098113	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.91	CHEMBL5334	Homo sapiens	Inhibition	%	-0.91
	8098233	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	67.25	CHEMBL5334	Homo sapiens	Inhibition	%	67.25
	8098457	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.87	CHEMBL5334	Homo sapiens	Inhibition	%	0.87
	8098637	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	75.24	CHEMBL5334	Homo sapiens	Inhibition	%	75.24
	8098822	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	34.72	CHEMBL5334	Homo sapiens	Inhibition	%	34.72
	8099190	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.53	CHEMBL5334	Homo sapiens	Inhibition	%	4.53
	8099332	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	82.2	CHEMBL5334	Homo sapiens	Inhibition	%	82.2
	8099556	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.64	CHEMBL5334	Homo sapiens	Inhibition	%	0.64
	8099750	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.18	CHEMBL5334	Homo sapiens	Inhibition	%	-0.18
	8099897	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	70.07	CHEMBL5334	Homo sapiens	Inhibition	%	70.07
	8100121	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.86	CHEMBL5334	Homo sapiens	Inhibition	%	4.86
	8100267	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	35.58	CHEMBL5334	Homo sapiens	Inhibition	%	35.58
	8100607	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.8	CHEMBL5334	Homo sapiens	Inhibition	%	6.8
	8100747	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.33	CHEMBL5334	Homo sapiens	Inhibition	%	-0.33
	8101131	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.12	CHEMBL5334	Homo sapiens	Inhibition	%	3.12
	8101273	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.12	CHEMBL5334	Homo sapiens	Inhibition	%	4.12
	8101497	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	4.15	CHEMBL5334	Homo sapiens	Inhibition	%	4.15
	8101682	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.02	CHEMBL5334	Homo sapiens	Inhibition	%	3.02
	8101935	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	10.04	CHEMBL5334	Homo sapiens	Inhibition	%	10.04
	8102090	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.87	CHEMBL5334	Homo sapiens	Inhibition	%	2.87
	8102314	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	6.88	CHEMBL5334	Homo sapiens	Inhibition	%	6.88
	8102445	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	17.44	CHEMBL5334	Homo sapiens	Inhibition	%	17.44
	8102789	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	12.12	CHEMBL5334	Homo sapiens	Inhibition	%	12.12
	8102967	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.53	CHEMBL5334	Homo sapiens	Inhibition	%	1.53
	8103163	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	74.13	CHEMBL5334	Homo sapiens	Inhibition	%	74.13
	8103387	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.23	CHEMBL5334	Homo sapiens	Inhibition	%	1.23
	8103525	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	7.58	CHEMBL5334	Homo sapiens	Inhibition	%	7.58
	8103899	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	23.58	CHEMBL5334	Homo sapiens	Inhibition	%	23.58
	8104084	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.77	CHEMBL5334	Homo sapiens	Inhibition	%	1.77
	8104456	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.73	CHEMBL5334	Homo sapiens	Inhibition	%	9.73
	8104602	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	9.41	CHEMBL5334	Homo sapiens	Inhibition	%	9.41
	8104940	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.15	CHEMBL5334	Homo sapiens	Inhibition	%	-0.15
	8105080	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	9.61	CHEMBL5334	Homo sapiens	Inhibition	%	9.61
	8105304	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.46	CHEMBL5334	Homo sapiens	Inhibition	%	1.46
	8105470	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.16	CHEMBL5334	Homo sapiens	Inhibition	%	5.16
	8105832	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	28.38	CHEMBL5334	Homo sapiens	Inhibition	%	28.38
	8106112	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.67	CHEMBL5334	Homo sapiens	Inhibition	%	0.67
	8106277	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	41.74	CHEMBL5334	Homo sapiens	Inhibition	%	41.74
	8106657	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	58.29	CHEMBL5334	Homo sapiens	Inhibition	%	58.29
	8106786	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	15.57	CHEMBL5334	Homo sapiens	Inhibition	%	15.57
	8107131	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.05	CHEMBL5334	Homo sapiens	Inhibition	%	1.05
	8107303	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	5.09	CHEMBL5334	Homo sapiens	Inhibition	%	5.09
	8107527	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.72	CHEMBL5334	Homo sapiens	Inhibition	%	1.72
	8107728	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-4.26	CHEMBL5334	Homo sapiens	Inhibition	%	-4.26
	8107863	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	6.18	CHEMBL5334	Homo sapiens	Inhibition	%	6.18
	8108087	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	44.29	CHEMBL5334	Homo sapiens	Inhibition	%	44.29
	8108245	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.58	CHEMBL5334	Homo sapiens	Inhibition	%	4.58
	8108420	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.25	CHEMBL5334	Homo sapiens	Inhibition	%	2.25
	8108791	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.13	CHEMBL5334	Homo sapiens	Inhibition	%	7.13
	8108933	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	44.37	CHEMBL5334	Homo sapiens	Inhibition	%	44.37
	8109157	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.59	CHEMBL5334	Homo sapiens	Inhibition	%	1.59
	8109271	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.6	CHEMBL5334	Homo sapiens	Inhibition	%	2.6
	8109625	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.53	CHEMBL5334	Homo sapiens	Inhibition	%	1.53
	8109796	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.41	CHEMBL5334	Homo sapiens	Inhibition	%	3.41
	8110152	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.49	CHEMBL5334	Homo sapiens	Inhibition	%	2.49
	8110431	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.04	CHEMBL5334	Homo sapiens	Inhibition	%	1.04
	8110597	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.15	CHEMBL5334	Homo sapiens	Inhibition	%	1.15
	8110821	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.39	CHEMBL5334	Homo sapiens	Inhibition	%	0.39
	8110979	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.24	CHEMBL5334	Homo sapiens	Inhibition	%	2.24
	8111102	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	72.06	CHEMBL5334	Homo sapiens	Inhibition	%	72.06
	8111326	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.34	CHEMBL5334	Homo sapiens	Inhibition	%	3.34
	8111453	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	11.24	CHEMBL5334	Homo sapiens	Inhibition	%	11.24
	8111843	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	5.51	CHEMBL5334	Homo sapiens	Inhibition	%	5.51
	8112048	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.78	CHEMBL5334	Homo sapiens	Inhibition	%	1.78
	8112409	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.41	CHEMBL5334	Homo sapiens	Inhibition	%	-1.41
	8112577	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	29.13	CHEMBL5334	Homo sapiens	Inhibition	%	29.13
	8112749	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	7.76	CHEMBL5334	Homo sapiens	Inhibition	%	7.76
	8112973	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.08	CHEMBL5334	Homo sapiens	Inhibition	%	1.08
	8113125	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	26.1	CHEMBL5334	Homo sapiens	Inhibition	%	26.1
	8113485	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.35	CHEMBL5334	Homo sapiens	Inhibition	%	5.35
	8113609	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.53	CHEMBL5334	Homo sapiens	Inhibition	%	0.53
	8113949	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.89	CHEMBL5334	Homo sapiens	Inhibition	%	-0.89
	8114125	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	18.09	CHEMBL5334	Homo sapiens	Inhibition	%	18.09
	8114349	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.64	CHEMBL5334	Homo sapiens	Inhibition	%	0.64
	8114481	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	31.06	CHEMBL5334	Homo sapiens	Inhibition	%	31.06
	8114757	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.56	CHEMBL5334	Homo sapiens	Inhibition	%	0.56
	8115147	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	10.68	CHEMBL5334	Homo sapiens	Inhibition	%	10.68
	8115312	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	10.61	CHEMBL5334	Homo sapiens	Inhibition	%	10.61
	8115656	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	13.82	CHEMBL5334	Homo sapiens	Inhibition	%	13.82
	8115789	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.04	CHEMBL5334	Homo sapiens	Inhibition	%	2.04
	8116013	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.67	CHEMBL5334	Homo sapiens	Inhibition	%	1.67
	8116172	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.66	CHEMBL5334	Homo sapiens	Inhibition	%	0.66
	8116375	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.17	CHEMBL5334	Homo sapiens	Inhibition	%	4.17
	8116733	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.13	CHEMBL5334	Homo sapiens	Inhibition	%	0.13
	8116905	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.81	CHEMBL5334	Homo sapiens	Inhibition	%	6.81
	8117300	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.74	CHEMBL5334	Homo sapiens	Inhibition	%	5.74
	8117458	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.64	CHEMBL5334	Homo sapiens	Inhibition	%	0.64
	8117812	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.4	CHEMBL5334	Homo sapiens	Inhibition	%	2.4
	8117950	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.06	CHEMBL5334	Homo sapiens	Inhibition	%	6.06
	8118174	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.22	CHEMBL5334	Homo sapiens	Inhibition	%	0.22
	8118290	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.9	CHEMBL5334	Homo sapiens	Inhibition	%	-3.9
	8118686	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.33	CHEMBL5334	Homo sapiens	Inhibition	%	5.33
	8118822	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.8	CHEMBL5334	Homo sapiens	Inhibition	%	1.8
	8119093	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-2.52	CHEMBL5334	Homo sapiens	Inhibition	%	-2.52
	8119476	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	50.02	CHEMBL5334	Homo sapiens	Inhibition	%	50.02
	8119643	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.47	CHEMBL5334	Homo sapiens	Inhibition	%	-0.47
	8119986	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.58	CHEMBL5334	Homo sapiens	Inhibition	%	4.58
	8120349	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.74	CHEMBL5334	Homo sapiens	Inhibition	%	-0.74
	8120509	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	10.3	CHEMBL5334	Homo sapiens	Inhibition	%	10.3
	8120710	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.33	CHEMBL5334	Homo sapiens	Inhibition	%	1.33
	8120934	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.26	CHEMBL5334	Homo sapiens	Inhibition	%	0.26
	8121062	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.2	CHEMBL5334	Homo sapiens	Inhibition	%	2.2
	8121234	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	35.96	CHEMBL5334	Homo sapiens	Inhibition	%	35.96
	8121458	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.66	CHEMBL5334	Homo sapiens	Inhibition	%	0.66
	8121625	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	12.79	CHEMBL5334	Homo sapiens	Inhibition	%	12.79
	8121788	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.22	CHEMBL5334	Homo sapiens	Inhibition	%	3.22
	8122012	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.8	CHEMBL5334	Homo sapiens	Inhibition	%	2.8
	8122133	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	11.3	CHEMBL5334	Homo sapiens	Inhibition	%	11.3
	8122495	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.28	CHEMBL5334	Homo sapiens	Inhibition	%	4.28
	8122615	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.66	CHEMBL5334	Homo sapiens	Inhibition	%	2.66
	8122839	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.9	CHEMBL5334	Homo sapiens	Inhibition	%	3.9
	8123006	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.17	CHEMBL5334	Homo sapiens	Inhibition	%	3.17
	8123148	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	16.97	CHEMBL5334	Homo sapiens	Inhibition	%	16.97
	8123372	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	12.49	CHEMBL5334	Homo sapiens	Inhibition	%	12.49
	8123426	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	30.76	CHEMBL5334	Homo sapiens	Inhibition	%	30.76
	8123650	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	73.43	CHEMBL5334	Homo sapiens	Inhibition	%	73.43
	8123800	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	10.77	CHEMBL5334	Homo sapiens	Inhibition	%	10.77
	8123967	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	13.14	CHEMBL5334	Homo sapiens	Inhibition	%	13.14
	8124191	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.98	CHEMBL5334	Homo sapiens	Inhibition	%	1.98
	8124310	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	27.08	CHEMBL5334	Homo sapiens	Inhibition	%	27.08
	8124673	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.22	CHEMBL5334	Homo sapiens	Inhibition	%	2.22
	8124838	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.45	CHEMBL5334	Homo sapiens	Inhibition	%	0.45
	8125263	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.24	CHEMBL5334	Homo sapiens	Inhibition	%	1.24
	8125393	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	9.9	CHEMBL5334	Homo sapiens	Inhibition	%	9.9
	8125785	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.45	CHEMBL5334	Homo sapiens	Inhibition	%	5.45
	8125949	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	14.71	CHEMBL5334	Homo sapiens	Inhibition	%	14.71
	8126337	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	18.87	CHEMBL5334	Homo sapiens	Inhibition	%	18.87
	8126452	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	2.54	CHEMBL5334	Homo sapiens	Inhibition	%	2.54
	8126676	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	25.75	CHEMBL5334	Homo sapiens	Inhibition	%	25.75
	8126812	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.89	CHEMBL5334	Homo sapiens	Inhibition	%	6.89
	8127158	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.72	CHEMBL5334	Homo sapiens	Inhibition	%	2.72
	8127325	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.41	CHEMBL5334	Homo sapiens	Inhibition	%	4.41
	8127691	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	59.13	CHEMBL5334	Homo sapiens	Inhibition	%	59.13
	8127979	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.56	CHEMBL5334	Homo sapiens	Inhibition	%	4.56
	8128131	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	51.11	CHEMBL5334	Homo sapiens	Inhibition	%	51.11
	8128522	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	19.33	CHEMBL5334	Homo sapiens	Inhibition	%	19.33
	8128641	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	15.29	CHEMBL5334	Homo sapiens	Inhibition	%	15.29
	8128865	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	65.89	CHEMBL5334	Homo sapiens	Inhibition	%	65.89
	8129002	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.38	CHEMBL5334	Homo sapiens	Inhibition	%	1.38
	8129173	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	9.52	CHEMBL5334	Homo sapiens	Inhibition	%	9.52
	8129397	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.33	CHEMBL5334	Homo sapiens	Inhibition	%	2.33
	8129586	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.88	CHEMBL5334	Homo sapiens	Inhibition	%	0.88
	8129725	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.13	CHEMBL5334	Homo sapiens	Inhibition	%	-1.13
	8129949	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.09	CHEMBL5334	Homo sapiens	Inhibition	%	0.09
	8130110	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.51	CHEMBL5334	Homo sapiens	Inhibition	%	0.51
	8130282	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.54	CHEMBL5334	Homo sapiens	Inhibition	%	1.54
	8130506	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.05	CHEMBL5334	Homo sapiens	Inhibition	%	0.05
	8130666	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.27	CHEMBL5334	Homo sapiens	Inhibition	%	5.27
	8131006	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.86	CHEMBL5334	Homo sapiens	Inhibition	%	-0.86
	8131145	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	37.81	CHEMBL5334	Homo sapiens	Inhibition	%	37.81
	8131489	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.92	CHEMBL5334	Homo sapiens	Inhibition	%	0.92
	8131656	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	27.41	CHEMBL5334	Homo sapiens	Inhibition	%	27.41
	8131880	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	76.51	CHEMBL5334	Homo sapiens	Inhibition	%	76.51
	8132021	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.73	CHEMBL5334	Homo sapiens	Inhibition	%	7.73
	8132307	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	23.81	CHEMBL5334	Homo sapiens	Inhibition	%	23.81
	8132454	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%		CHEMBL5334	Homo sapiens	Inhibition	%	
	8132678	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.79	CHEMBL5334	Homo sapiens	Inhibition	%	1.79
	8132846	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.57	CHEMBL5334	Homo sapiens	Inhibition	%	2.57
	8133191	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.4	CHEMBL5334	Homo sapiens	Inhibition	%	2.4
	8133329	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	16.71	CHEMBL5334	Homo sapiens	Inhibition	%	16.71
	8133725	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	20.81	CHEMBL5334	Homo sapiens	Inhibition	%	20.81
	8133905	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	46.25	CHEMBL5334	Homo sapiens	Inhibition	%	46.25
	8134277	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.85	CHEMBL5334	Homo sapiens	Inhibition	%	-0.85
	8134437	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.99	CHEMBL5334	Homo sapiens	Inhibition	%	4.99
	8134845	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.85	CHEMBL5334	Homo sapiens	Inhibition	%	-2.85
	8135005	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	32.04	CHEMBL5334	Homo sapiens	Inhibition	%	32.04
	8135344	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.97	CHEMBL5334	Homo sapiens	Inhibition	%	2.97
	8135485	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.7	CHEMBL5334	Homo sapiens	Inhibition	%	0.7
	8135709	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.31	CHEMBL5334	Homo sapiens	Inhibition	%	4.31
	8135830	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.48	CHEMBL5334	Homo sapiens	Inhibition	%	2.48
	8136222	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.36	CHEMBL5334	Homo sapiens	Inhibition	%	0.36
	8136366	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	52.81	CHEMBL5334	Homo sapiens	Inhibition	%	52.81
	8136656	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.97	CHEMBL5334	Homo sapiens	Inhibition	%	1.97
	8137015	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.39	CHEMBL5334	Homo sapiens	Inhibition	%	-0.39
	8137178	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	27.69	CHEMBL5334	Homo sapiens	Inhibition	%	27.69
	8137522	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	14.81	CHEMBL5334	Homo sapiens	Inhibition	%	14.81
	8137670	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.03	CHEMBL5334	Homo sapiens	Inhibition	%	1.03
	8137894	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.94	CHEMBL5334	Homo sapiens	Inhibition	%	4.94
	8138060	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.62	CHEMBL5334	Homo sapiens	Inhibition	%	-2.62
	8138239	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%		CHEMBL5334	Homo sapiens	Inhibition	%	
	8138611	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	6.1	CHEMBL5334	Homo sapiens	Inhibition	%	6.1
	8138769	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.21	CHEMBL5334	Homo sapiens	Inhibition	%	0.21
	8138993	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.38	CHEMBL5334	Homo sapiens	Inhibition	%	5.38
	8139178	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	6.96	CHEMBL5334	Homo sapiens	Inhibition	%	6.96
	8139337	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	9.02	CHEMBL5334	Homo sapiens	Inhibition	%	9.02
	8139561	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	50.77	CHEMBL5334	Homo sapiens	Inhibition	%	50.77
	8139675	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.84	CHEMBL5334	Homo sapiens	Inhibition	%	1.84
	8140040	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.94	CHEMBL5334	Homo sapiens	Inhibition	%	2.94
	8140163	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.8	CHEMBL5334	Homo sapiens	Inhibition	%	1.8
	8140387	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.93	CHEMBL5334	Homo sapiens	Inhibition	%	2.93
	8140546	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.79	CHEMBL5334	Homo sapiens	Inhibition	%	3.79
	8140689	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.93	CHEMBL5334	Homo sapiens	Inhibition	%	3.93
	8140913	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.31	CHEMBL5334	Homo sapiens	Inhibition	%	7.31
	8140991	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	6.22	CHEMBL5334	Homo sapiens	Inhibition	%	6.22
	8141345	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	9.22	CHEMBL5334	Homo sapiens	Inhibition	%	9.22
	8141505	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.78	CHEMBL5334	Homo sapiens	Inhibition	%	9.78
	8141729	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	47.95	CHEMBL5334	Homo sapiens	Inhibition	%	47.95
	8141848	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.82	CHEMBL5334	Homo sapiens	Inhibition	%	0.82
	8142233	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.95	CHEMBL5334	Homo sapiens	Inhibition	%	6.95
	8142401	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.58	CHEMBL5334	Homo sapiens	Inhibition	%	-0.58
	8142577	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.85	CHEMBL5334	Homo sapiens	Inhibition	%	0.85
	8142801	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.82	CHEMBL5334	Homo sapiens	Inhibition	%	2.82
	8142950	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.74	CHEMBL5334	Homo sapiens	Inhibition	%	-4.74
	8143329	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.01	CHEMBL5334	Homo sapiens	Inhibition	%	-0.01
	8143516	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	22.7	CHEMBL5334	Homo sapiens	Inhibition	%	22.7
	8143899	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.78	CHEMBL5334	Homo sapiens	Inhibition	%	2.78
	8144013	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	9.92	CHEMBL5334	Homo sapiens	Inhibition	%	9.92
	8144376	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	11.7	CHEMBL5334	Homo sapiens	Inhibition	%	11.7
	8144730	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.92	CHEMBL5334	Homo sapiens	Inhibition	%	4.92
	8144883	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.65	CHEMBL5334	Homo sapiens	Inhibition	%	2.65
	8145244	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.16	CHEMBL5334	Homo sapiens	Inhibition	%	4.16
	8145333	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.17	CHEMBL5334	Homo sapiens	Inhibition	%	1.17
	8145557	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	12.04	CHEMBL5334	Homo sapiens	Inhibition	%	12.04
	8145681	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.16	CHEMBL5334	Homo sapiens	Inhibition	%	0.16
	8146066	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	59.8	CHEMBL5334	Homo sapiens	Inhibition	%	59.8
	8146186	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	16.54	CHEMBL5334	Homo sapiens	Inhibition	%	16.54
	8146410	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.15	CHEMBL5334	Homo sapiens	Inhibition	%	2.15
	8146570	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	51.11	CHEMBL5334	Homo sapiens	Inhibition	%	51.11
	8146737	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.21	CHEMBL5334	Homo sapiens	Inhibition	%	3.21
	8147130	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.52	CHEMBL5334	Homo sapiens	Inhibition	%	0.52
	8147272	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-5.58	CHEMBL5334	Homo sapiens	Inhibition	%	-5.58
	8147496	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.51	CHEMBL5334	Homo sapiens	Inhibition	%	1.51
	8147649	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%		CHEMBL5334	Homo sapiens	Inhibition	%	
	8147836	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	84.51	CHEMBL5334	Homo sapiens	Inhibition	%	84.51
	8148218	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	19.46	CHEMBL5334	Homo sapiens	Inhibition	%	19.46
	8148332	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.59	CHEMBL5334	Homo sapiens	Inhibition	%	0.59
	8148556	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	14.56	CHEMBL5334	Homo sapiens	Inhibition	%	14.56
	8148695	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-2.21	CHEMBL5334	Homo sapiens	Inhibition	%	-2.21
	8149057	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.4	CHEMBL5334	Homo sapiens	Inhibition	%	4.4
	8149216	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.41	CHEMBL5334	Homo sapiens	Inhibition	%	2.41
	8149574	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	22.31	CHEMBL5334	Homo sapiens	Inhibition	%	22.31
	8149896	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.27	CHEMBL5334	Homo sapiens	Inhibition	%	1.27
	8150021	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.24	CHEMBL5334	Homo sapiens	Inhibition	%	1.24
	8150245	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	9.16	CHEMBL5334	Homo sapiens	Inhibition	%	9.16
	8150405	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	84.08	CHEMBL5334	Homo sapiens	Inhibition	%	84.08
	8150749	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	25.33	CHEMBL5334	Homo sapiens	Inhibition	%	25.33
	8150914	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	32.34	CHEMBL5334	Homo sapiens	Inhibition	%	32.34
	8151077	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	30.26	CHEMBL5334	Homo sapiens	Inhibition	%	30.26
	8151301	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.01	CHEMBL5334	Homo sapiens	Inhibition	%	-1.01
	8151478	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.06	CHEMBL5334	Homo sapiens	Inhibition	%	6.06
	8151840	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.59	CHEMBL5334	Homo sapiens	Inhibition	%	8.59
	8151994	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	7.47	CHEMBL5334	Homo sapiens	Inhibition	%	7.47
	8152182	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	25.54	CHEMBL5334	Homo sapiens	Inhibition	%	25.54
	8152406	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	70.15	CHEMBL5334	Homo sapiens	Inhibition	%	70.15
	8152564	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.05	CHEMBL5334	Homo sapiens	Inhibition	%	5.05
	8152902	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	39.98	CHEMBL5334	Homo sapiens	Inhibition	%	39.98
	8153041	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.9	CHEMBL5334	Homo sapiens	Inhibition	%	3.9
	8153265	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.88	CHEMBL5334	Homo sapiens	Inhibition	%	2.88
	8153402	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.01	CHEMBL5334	Homo sapiens	Inhibition	%	4.01
	8153559	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.76	CHEMBL5334	Homo sapiens	Inhibition	%	2.76
	8153783	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	23.22	CHEMBL5334	Homo sapiens	Inhibition	%	23.22
	8153916	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.07	CHEMBL5334	Homo sapiens	Inhibition	%	-0.07
	8154237	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	14.58	CHEMBL5334	Homo sapiens	Inhibition	%	14.58
	8154587	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	58.56	CHEMBL5334	Homo sapiens	Inhibition	%	58.56
	8154746	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.06	CHEMBL5334	Homo sapiens	Inhibition	%	-0.06
	8155090	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.06	CHEMBL5334	Homo sapiens	Inhibition	%	1.06
	8155266	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	80.19	CHEMBL5334	Homo sapiens	Inhibition	%	80.19
	8155651	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	4.02	CHEMBL5334	Homo sapiens	Inhibition	%	4.02
	8155829	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.41	CHEMBL5334	Homo sapiens	Inhibition	%	1.41
	8156191	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.72	CHEMBL5334	Homo sapiens	Inhibition	%	-0.72
	8156403	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.89	CHEMBL5334	Homo sapiens	Inhibition	%	8.89
	8156777	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	66.89	CHEMBL5334	Homo sapiens	Inhibition	%	66.89
	8156920	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.37	CHEMBL5334	Homo sapiens	Inhibition	%	4.37
	8157264	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.09	CHEMBL5334	Homo sapiens	Inhibition	%	6.09
	8157405	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	85.34	CHEMBL5334	Homo sapiens	Inhibition	%	85.34
	8157629	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	15.21	CHEMBL5334	Homo sapiens	Inhibition	%	15.21
	8157759	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	39.99	CHEMBL5334	Homo sapiens	Inhibition	%	39.99
	8158144	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-8.3	CHEMBL5334	Homo sapiens	Inhibition	%	-8.3
	8158394	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	29.31	CHEMBL5334	Homo sapiens	Inhibition	%	29.31
	8158552	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.43	CHEMBL5334	Homo sapiens	Inhibition	%	2.43
	8158945	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.68	CHEMBL5334	Homo sapiens	Inhibition	%	1.68
	8159080	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.89	CHEMBL5334	Homo sapiens	Inhibition	%	8.89
	8159304	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.45	CHEMBL5334	Homo sapiens	Inhibition	%	4.45
	8159424	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.87	CHEMBL5334	Homo sapiens	Inhibition	%	3.87
	8159779	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.43	CHEMBL5334	Homo sapiens	Inhibition	%	7.43
	8159920	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.76	CHEMBL5334	Homo sapiens	Inhibition	%	0.76
	8160281	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.32	CHEMBL5334	Homo sapiens	Inhibition	%	3.32
	8160431	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.41	CHEMBL5334	Homo sapiens	Inhibition	%	-0.41
	8160655	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-3.34	CHEMBL5334	Homo sapiens	Inhibition	%	-3.34
	8160725	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.37	CHEMBL5334	Homo sapiens	Inhibition	%	3.37
	8161099	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	15.54	CHEMBL5334	Homo sapiens	Inhibition	%	15.54
	8161242	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	18.53	CHEMBL5334	Homo sapiens	Inhibition	%	18.53
	8161466	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	18.14	CHEMBL5334	Homo sapiens	Inhibition	%	18.14
	8161591	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	31.32	CHEMBL5334	Homo sapiens	Inhibition	%	31.32
	8161953	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	48.84	CHEMBL5334	Homo sapiens	Inhibition	%	48.84
	8162083	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.18	CHEMBL5334	Homo sapiens	Inhibition	%	1.18
	8162307	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	16.11	CHEMBL5334	Homo sapiens	Inhibition	%	16.11
	8162467	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.25	CHEMBL5334	Homo sapiens	Inhibition	%	-0.25
	8162720	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.94	CHEMBL5334	Homo sapiens	Inhibition	%	2.94
	8162868	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.64	CHEMBL5334	Homo sapiens	Inhibition	%	-2.64
	8163092	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	15.59	CHEMBL5334	Homo sapiens	Inhibition	%	15.59
	8163261	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.03	CHEMBL5334	Homo sapiens	Inhibition	%	7.03
	8163619	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	21.92	CHEMBL5334	Homo sapiens	Inhibition	%	21.92
	8163742	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.74	CHEMBL5334	Homo sapiens	Inhibition	%	0.74
	8163966	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.59	CHEMBL5334	Homo sapiens	Inhibition	%	2.59
	8164100	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	41.22	CHEMBL5334	Homo sapiens	Inhibition	%	41.22
	8164240	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.08	CHEMBL5334	Homo sapiens	Inhibition	%	0.08
	8164464	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.43	CHEMBL5334	Homo sapiens	Inhibition	%	-0.43
	8164619	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.64	CHEMBL5334	Homo sapiens	Inhibition	%	8.64
	8164987	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	8.33	CHEMBL5334	Homo sapiens	Inhibition	%	8.33
	8165057	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.56	CHEMBL5334	Homo sapiens	Inhibition	%	6.56
	8165281	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	50.03	CHEMBL5334	Homo sapiens	Inhibition	%	50.03
	8165422	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	63.48	CHEMBL5334	Homo sapiens	Inhibition	%	63.48
	8165789	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	64.46	CHEMBL5334	Homo sapiens	Inhibition	%	64.46
	8165915	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.82	CHEMBL5334	Homo sapiens	Inhibition	%	3.82
	8166139	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.57	CHEMBL5334	Homo sapiens	Inhibition	%	2.57
	8166277	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.68	CHEMBL5334	Homo sapiens	Inhibition	%	2.68
	8166631	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.62	CHEMBL5334	Homo sapiens	Inhibition	%	3.62
	8166732	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	43.03	CHEMBL5334	Homo sapiens	Inhibition	%	43.03
	8166956	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	77.34	CHEMBL5334	Homo sapiens	Inhibition	%	77.34
	8167044	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.95	CHEMBL5334	Homo sapiens	Inhibition	%	2.95
	8167409	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	53.12	CHEMBL5334	Homo sapiens	Inhibition	%	53.12
	8167573	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.31	CHEMBL5334	Homo sapiens	Inhibition	%	1.31
	8167930	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.71	CHEMBL5334	Homo sapiens	Inhibition	%	7.71
	8168278	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.95	CHEMBL5334	Homo sapiens	Inhibition	%	4.95
	8168419	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	81.05	CHEMBL5334	Homo sapiens	Inhibition	%	81.05
	8168779	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.61	CHEMBL5334	Homo sapiens	Inhibition	%	-1.61
	8168943	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.87	CHEMBL5334	Homo sapiens	Inhibition	%	11.87
	8169309	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.68	CHEMBL5334	Homo sapiens	Inhibition	%	2.68
	8169613	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	73.02	CHEMBL5334	Homo sapiens	Inhibition	%	73.02
	8169747	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.9	CHEMBL5334	Homo sapiens	Inhibition	%	2.9
	8169971	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	11.52	CHEMBL5334	Homo sapiens	Inhibition	%	11.52
	8170116	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.85	CHEMBL5334	Homo sapiens	Inhibition	%	4.85
	8170465	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.15	CHEMBL5334	Homo sapiens	Inhibition	%	2.15
	8170605	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	16.19	CHEMBL5334	Homo sapiens	Inhibition	%	16.19
	8170964	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	12.28	CHEMBL5334	Homo sapiens	Inhibition	%	12.28
	8171161	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.81	CHEMBL5334	Homo sapiens	Inhibition	%	4.81
	8171378	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.95	CHEMBL5334	Homo sapiens	Inhibition	%	0.95
	8171602	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.9	CHEMBL5334	Homo sapiens	Inhibition	%	5.9
	8171743	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	60.54	CHEMBL5334	Homo sapiens	Inhibition	%	60.54
	8171896	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-2.02	CHEMBL5334	Homo sapiens	Inhibition	%	-2.02
	8172120	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.13	CHEMBL5334	Homo sapiens	Inhibition	%	2.13
	8172252	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.97	CHEMBL5334	Homo sapiens	Inhibition	%	9.97
	8172604	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	31.18	CHEMBL5334	Homo sapiens	Inhibition	%	31.18
	8172746	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.67	CHEMBL5334	Homo sapiens	Inhibition	%	4.67
	8172970	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.83	CHEMBL5334	Homo sapiens	Inhibition	%	2.83
	8173106	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.18	CHEMBL5334	Homo sapiens	Inhibition	%	-2.18
	8173271	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	52.28	CHEMBL5334	Homo sapiens	Inhibition	%	52.28
	8173495	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	10.1	CHEMBL5334	Homo sapiens	Inhibition	%	10.1
	8173636	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.17	CHEMBL5334	Homo sapiens	Inhibition	%	5.17
	8173947	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.59	CHEMBL5334	Homo sapiens	Inhibition	%	1.59
	8174303	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.05	CHEMBL5334	Homo sapiens	Inhibition	%	4.05
	8174451	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	33.81	CHEMBL5334	Homo sapiens	Inhibition	%	33.81
	8174797	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.82	CHEMBL5334	Homo sapiens	Inhibition	%	5.82
	8174940	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.75	CHEMBL5334	Homo sapiens	Inhibition	%	1.75
	8175164	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	10.55	CHEMBL5334	Homo sapiens	Inhibition	%	10.55
	8175300	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	5.68	CHEMBL5334	Homo sapiens	Inhibition	%	5.68
	8175556	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.41	CHEMBL5334	Homo sapiens	Inhibition	%	2.41
	8175943	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	30.03	CHEMBL5334	Homo sapiens	Inhibition	%	30.03
	8176096	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	89.26	CHEMBL5334	Homo sapiens	Inhibition	%	89.26
	8176469	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.44	CHEMBL5334	Homo sapiens	Inhibition	%	2.44
	8176601	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.65	CHEMBL5334	Homo sapiens	Inhibition	%	4.65
	8176825	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	21.34	CHEMBL5334	Homo sapiens	Inhibition	%	21.34
	8176955	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.4	CHEMBL5334	Homo sapiens	Inhibition	%	-0.4
	8177321	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	35.15	CHEMBL5334	Homo sapiens	Inhibition	%	35.15
	8177459	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.91	CHEMBL5334	Homo sapiens	Inhibition	%	2.91
	8177847	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	52.29	CHEMBL5334	Homo sapiens	Inhibition	%	52.29
	8177987	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	52.5	CHEMBL5334	Homo sapiens	Inhibition	%	52.5
	8178211	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	80.57	CHEMBL5334	Homo sapiens	Inhibition	%	80.57
	8178299	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	10.13	CHEMBL5334	Homo sapiens	Inhibition	%	10.13
	8178650	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	20.02	CHEMBL5334	Homo sapiens	Inhibition	%	20.02
	8178799	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.89	CHEMBL5334	Homo sapiens	Inhibition	%	1.89
	8179023	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-2.48	CHEMBL5334	Homo sapiens	Inhibition	%	-2.48
	8179146	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.2	CHEMBL5334	Homo sapiens	Inhibition	%	3.2
	8179514	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.58	CHEMBL5334	Homo sapiens	Inhibition	%	3.58
	8179651	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	49.26	CHEMBL5334	Homo sapiens	Inhibition	%	49.26
	8179908	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	14.04	CHEMBL5334	Homo sapiens	Inhibition	%	14.04
	8180286	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	80.65	CHEMBL5334	Homo sapiens	Inhibition	%	80.65
	8180442	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.04	CHEMBL5334	Homo sapiens	Inhibition	%	5.04
	8180666	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.5	CHEMBL5334	Homo sapiens	Inhibition	%	3.5
	8180814	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.71	CHEMBL5334	Homo sapiens	Inhibition	%	0.71
	8181171	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.13	CHEMBL5334	Homo sapiens	Inhibition	%	4.13
	8181302	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.89	CHEMBL5334	Homo sapiens	Inhibition	%	5.89
	8181666	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	84.24	CHEMBL5334	Homo sapiens	Inhibition	%	84.24
	8181805	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	63.64	CHEMBL5334	Homo sapiens	Inhibition	%	63.64
	8182029	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	89.01	CHEMBL5334	Homo sapiens	Inhibition	%	89.01
	8182192	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.65	CHEMBL5334	Homo sapiens	Inhibition	%	4.65
	8182556	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.85	CHEMBL5334	Homo sapiens	Inhibition	%	3.85
	8182648	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.02	CHEMBL5334	Homo sapiens	Inhibition	%	1.02
	8182872	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	11.98	CHEMBL5334	Homo sapiens	Inhibition	%	11.98
	8182994	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.45	CHEMBL5334	Homo sapiens	Inhibition	%	5.45
	8183367	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	48.95	CHEMBL5334	Homo sapiens	Inhibition	%	48.95
	8183496	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	10.33	CHEMBL5334	Homo sapiens	Inhibition	%	10.33
	8183862	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	17.46	CHEMBL5334	Homo sapiens	Inhibition	%	17.46
	8183998	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.24	CHEMBL5334	Homo sapiens	Inhibition	%	1.24
	8184222	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	11.97	CHEMBL5334	Homo sapiens	Inhibition	%	11.97
	8184264	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.98	CHEMBL5334	Homo sapiens	Inhibition	%	2.98
	8184488	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.95	CHEMBL5334	Homo sapiens	Inhibition	%	7.95
	8184635	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.22	CHEMBL5334	Homo sapiens	Inhibition	%	1.22
	8185016	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	8.48	CHEMBL5334	Homo sapiens	Inhibition	%	8.48
	8185165	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.7	CHEMBL5334	Homo sapiens	Inhibition	%	5.7
	8185520	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	13.73	CHEMBL5334	Homo sapiens	Inhibition	%	13.73
	8185651	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.91	CHEMBL5334	Homo sapiens	Inhibition	%	-3.91
	8185875	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.56	CHEMBL5334	Homo sapiens	Inhibition	%	9.56
	8186014	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.15	CHEMBL5334	Homo sapiens	Inhibition	%	3.15
	8186379	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.48	CHEMBL5334	Homo sapiens	Inhibition	%	4.48
	8186543	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.8	CHEMBL5334	Homo sapiens	Inhibition	%	6.8
	8186906	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.46	CHEMBL5334	Homo sapiens	Inhibition	%	-0.46
	8187228	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.23	CHEMBL5334	Homo sapiens	Inhibition	%	4.23
	8187352	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	12.43	CHEMBL5334	Homo sapiens	Inhibition	%	12.43
	8187724	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	90.64	CHEMBL5334	Homo sapiens	Inhibition	%	90.64
	8187853	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.18	CHEMBL5334	Homo sapiens	Inhibition	%	6.18
	8188077	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	22.23	CHEMBL5334	Homo sapiens	Inhibition	%	22.23
	8188220	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.04	CHEMBL5334	Homo sapiens	Inhibition	%	3.04
	8188579	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	10.43	CHEMBL5334	Homo sapiens	Inhibition	%	10.43
	8188853	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.1	CHEMBL5334	Homo sapiens	Inhibition	%	6.1
	8189001	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.7	CHEMBL5334	Homo sapiens	Inhibition	%	1.7
	8189381	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	30.36	CHEMBL5334	Homo sapiens	Inhibition	%	30.36
	8189530	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.56	CHEMBL5334	Homo sapiens	Inhibition	%	-1.56
	8189754	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.3	CHEMBL5334	Homo sapiens	Inhibition	%	-1.3
	8189886	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.31	CHEMBL5334	Homo sapiens	Inhibition	%	2.31
	8190242	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	40.2	CHEMBL5334	Homo sapiens	Inhibition	%	40.2
	8190382	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	7.79	CHEMBL5334	Homo sapiens	Inhibition	%	7.79
	8190743	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.68	CHEMBL5334	Homo sapiens	Inhibition	%	9.68
	8190907	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.3	CHEMBL5334	Homo sapiens	Inhibition	%	4.3
	8191131	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	13.86	CHEMBL5334	Homo sapiens	Inhibition	%	13.86
	8191269	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	12.71	CHEMBL5334	Homo sapiens	Inhibition	%	12.71
	8191589	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	14.42	CHEMBL5334	Homo sapiens	Inhibition	%	14.42
	8191711	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	9.21	CHEMBL5334	Homo sapiens	Inhibition	%	9.21
	8191935	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	44.96	CHEMBL5334	Homo sapiens	Inhibition	%	44.96
	8192084	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.96	CHEMBL5334	Homo sapiens	Inhibition	%	5.96
	8192437	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.31	CHEMBL5334	Homo sapiens	Inhibition	%	6.31
	8192581	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	20.48	CHEMBL5334	Homo sapiens	Inhibition	%	20.48
	8192805	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.86	CHEMBL5334	Homo sapiens	Inhibition	%	3.86
	8192941	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	20.01	CHEMBL5334	Homo sapiens	Inhibition	%	20.01
	8193213	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	23.14	CHEMBL5334	Homo sapiens	Inhibition	%	23.14
	8193358	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.37	CHEMBL5334	Homo sapiens	Inhibition	%	1.37
	8193582	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.79	CHEMBL5334	Homo sapiens	Inhibition	%	7.79
	8193739	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.06	CHEMBL5334	Homo sapiens	Inhibition	%	3.06
	8194112	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.68	CHEMBL5334	Homo sapiens	Inhibition	%	-3.68
	8194243	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	20.87	CHEMBL5334	Homo sapiens	Inhibition	%	20.87
	8194598	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	80.4	CHEMBL5334	Homo sapiens	Inhibition	%	80.4
	8194741	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.93	CHEMBL5334	Homo sapiens	Inhibition	%	1.93
	8194965	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.5	CHEMBL5334	Homo sapiens	Inhibition	%	6.5
	8195098	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.89	CHEMBL5334	Homo sapiens	Inhibition	%	4.89
	8195486	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	38.85	CHEMBL5334	Homo sapiens	Inhibition	%	38.85
	8195625	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	47.09	CHEMBL5334	Homo sapiens	Inhibition	%	47.09
	8195947	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.86	CHEMBL5334	Homo sapiens	Inhibition	%	1.86
	8196288	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.92	CHEMBL5334	Homo sapiens	Inhibition	%	1.92
	8196438	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	10.21	CHEMBL5334	Homo sapiens	Inhibition	%	10.21
	8196790	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	16.0	CHEMBL5334	Homo sapiens	Inhibition	%	16.0
	8197155	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	20.73	CHEMBL5334	Homo sapiens	Inhibition	%	20.73
	8197292	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.46	CHEMBL5334	Homo sapiens	Inhibition	%	2.46
	8197567	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.42	CHEMBL5334	Homo sapiens	Inhibition	%	3.42
	8197931	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	16.91	CHEMBL5334	Homo sapiens	Inhibition	%	16.91
	8198088	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.85	CHEMBL5334	Homo sapiens	Inhibition	%	5.85
	8198450	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.3	CHEMBL5334	Homo sapiens	Inhibition	%	-3.3
	8198580	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.34	CHEMBL5334	Homo sapiens	Inhibition	%	5.34
	8198804	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	23.77	CHEMBL5334	Homo sapiens	Inhibition	%	23.77
	8198935	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.03	CHEMBL5334	Homo sapiens	Inhibition	%	4.03
	8199307	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.39	CHEMBL5334	Homo sapiens	Inhibition	%	6.39
	8199441	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	10.79	CHEMBL5334	Homo sapiens	Inhibition	%	10.79
	8199665	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.37	CHEMBL5334	Homo sapiens	Inhibition	%	1.37
	8199828	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	85.35	CHEMBL5334	Homo sapiens	Inhibition	%	85.35
	8199966	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.37	CHEMBL5334	Homo sapiens	Inhibition	%	5.37
	8200190	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-4.68	CHEMBL5334	Homo sapiens	Inhibition	%	-4.68
	8200294	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.12	CHEMBL5334	Homo sapiens	Inhibition	%	7.12
	8200633	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	11.4	CHEMBL5334	Homo sapiens	Inhibition	%	11.4
	8200783	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.52	CHEMBL5334	Homo sapiens	Inhibition	%	3.52
	8201007	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.16	CHEMBL5334	Homo sapiens	Inhibition	%	14.16
	8201137	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	10.41	CHEMBL5334	Homo sapiens	Inhibition	%	10.41
	8201496	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.48	CHEMBL5334	Homo sapiens	Inhibition	%	3.48
	8201629	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	12.43	CHEMBL5334	Homo sapiens	Inhibition	%	12.43
	8201853	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-3.02	CHEMBL5334	Homo sapiens	Inhibition	%	-3.02
	8201908	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.48	CHEMBL5334	Homo sapiens	Inhibition	%	7.48
	8202132	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.87	CHEMBL5334	Homo sapiens	Inhibition	%	4.87
	8202272	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	63.16	CHEMBL5334	Homo sapiens	Inhibition	%	63.16
	8202439	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.24	CHEMBL5334	Homo sapiens	Inhibition	%	1.24
	8202663	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.81	CHEMBL5334	Homo sapiens	Inhibition	%	-1.81
	8202788	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.71	CHEMBL5334	Homo sapiens	Inhibition	%	3.71
	8203142	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.76	CHEMBL5334	Homo sapiens	Inhibition	%	2.76
	8203273	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-0.43	CHEMBL5334	Homo sapiens	Inhibition	%	-0.43
	8203497	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	16.58	CHEMBL5334	Homo sapiens	Inhibition	%	16.58
	8203643	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	21.03	CHEMBL5334	Homo sapiens	Inhibition	%	21.03
	8204001	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.13	CHEMBL5334	Homo sapiens	Inhibition	%	9.13
	8204167	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.08	CHEMBL5334	Homo sapiens	Inhibition	%	2.08
	8204528	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	8.49	CHEMBL5334	Homo sapiens	Inhibition	%	8.49
	8204633	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-6.06	CHEMBL5334	Homo sapiens	Inhibition	%	-6.06
	8204857	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	11.21	CHEMBL5334	Homo sapiens	Inhibition	%	11.21
	8204972	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.02	CHEMBL5334	Homo sapiens	Inhibition	%	4.02
	8205345	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.07	CHEMBL5334	Homo sapiens	Inhibition	%	4.07
	8205481	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	53.87	CHEMBL5334	Homo sapiens	Inhibition	%	53.87
	8205705	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.63	CHEMBL5334	Homo sapiens	Inhibition	%	2.63
	8205844	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	16.02	CHEMBL5334	Homo sapiens	Inhibition	%	16.02
	8206200	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	12.52	CHEMBL5334	Homo sapiens	Inhibition	%	12.52
	8206476	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	10.46	CHEMBL5334	Homo sapiens	Inhibition	%	10.46
	8206619	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.05	CHEMBL5334	Homo sapiens	Inhibition	%	0.05
	8207023	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.08	CHEMBL5334	Homo sapiens	Inhibition	%	1.08
	8207149	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	17.82	CHEMBL5334	Homo sapiens	Inhibition	%	17.82
	8207373	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.08	CHEMBL5334	Homo sapiens	Inhibition	%	3.08
	8207503	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.19	CHEMBL5334	Homo sapiens	Inhibition	%	9.19
	8207859	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	60.08	CHEMBL5334	Homo sapiens	Inhibition	%	60.08
	8208004	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.04	CHEMBL5334	Homo sapiens	Inhibition	%	1.04
	8208360	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.34	CHEMBL5334	Homo sapiens	Inhibition	%	4.34
	8208526	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	15.65	CHEMBL5334	Homo sapiens	Inhibition	%	15.65
	8208750	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.25	CHEMBL5334	Homo sapiens	Inhibition	%	3.25
	8208883	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	38.14	CHEMBL5334	Homo sapiens	Inhibition	%	38.14
	8209212	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	14.13	CHEMBL5334	Homo sapiens	Inhibition	%	14.13
	8209328	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	18.89	CHEMBL5334	Homo sapiens	Inhibition	%	18.89
	8209552	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.7	CHEMBL5334	Homo sapiens	Inhibition	%	3.7
	8209702	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	17.76	CHEMBL5334	Homo sapiens	Inhibition	%	17.76
	8210062	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	20.1	CHEMBL5334	Homo sapiens	Inhibition	%	20.1
	8210203	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.27	CHEMBL5334	Homo sapiens	Inhibition	%	2.27
	8210563	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-7.55	CHEMBL5334	Homo sapiens	Inhibition	%	-7.55
	8210822	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.68	CHEMBL5334	Homo sapiens	Inhibition	%	0.68
	8210966	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	37.06	CHEMBL5334	Homo sapiens	Inhibition	%	37.06
	8211190	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	8.49	CHEMBL5334	Homo sapiens	Inhibition	%	8.49
	8211360	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-3.93	CHEMBL5334	Homo sapiens	Inhibition	%	-3.93
	8211707	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	11.51	CHEMBL5334	Homo sapiens	Inhibition	%	11.51
	8211836	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.45	CHEMBL5334	Homo sapiens	Inhibition	%	4.45
	8212192	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.24	CHEMBL5334	Homo sapiens	Inhibition	%	1.24
	8212333	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-1.51	CHEMBL5334	Homo sapiens	Inhibition	%	-1.51
	8212557	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.9	CHEMBL5334	Homo sapiens	Inhibition	%	0.9
	8212690	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	11.86	CHEMBL5334	Homo sapiens	Inhibition	%	11.86
	8213084	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	22.36	CHEMBL5334	Homo sapiens	Inhibition	%	22.36
	8213213	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.99	CHEMBL5334	Homo sapiens	Inhibition	%	3.99
	8213541	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	61.82	CHEMBL5334	Homo sapiens	Inhibition	%	61.82
	8213878	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.67	CHEMBL5334	Homo sapiens	Inhibition	%	5.67
	8214025	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.11	CHEMBL5334	Homo sapiens	Inhibition	%	2.11
	8214386	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	17.73	CHEMBL5334	Homo sapiens	Inhibition	%	17.73
	8214520	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	10.1	CHEMBL5334	Homo sapiens	Inhibition	%	10.1
	8214744	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	8.82	CHEMBL5334	Homo sapiens	Inhibition	%	8.82
	8214896	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	4.72	CHEMBL5334	Homo sapiens	Inhibition	%	4.72
	8215147	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.31	CHEMBL5334	Homo sapiens	Inhibition	%	5.31
	8215524	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.49	CHEMBL5334	Homo sapiens	Inhibition	%	4.49
	8215688	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.48	CHEMBL5334	Homo sapiens	Inhibition	%	2.48
	8216031	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	14.7	CHEMBL5334	Homo sapiens	Inhibition	%	14.7
	8216150	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	20.35	CHEMBL5334	Homo sapiens	Inhibition	%	20.35
	8216374	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.47	CHEMBL5334	Homo sapiens	Inhibition	%	1.47
	8216510	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.7	CHEMBL5334	Homo sapiens	Inhibition	%	4.7
	8216872	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.38	CHEMBL5334	Homo sapiens	Inhibition	%	5.38
	8217006	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.91	CHEMBL5334	Homo sapiens	Inhibition	%	2.91
	8217230	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	11.35	CHEMBL5334	Homo sapiens	Inhibition	%	11.35
	8217404	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.99	CHEMBL5334	Homo sapiens	Inhibition	%	0.99
	8217535	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.35	CHEMBL5334	Homo sapiens	Inhibition	%	9.35
	8217759	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	38.6	CHEMBL5334	Homo sapiens	Inhibition	%	38.6
	8217860	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.22	CHEMBL5334	Homo sapiens	Inhibition	%	-3.22
	8218199	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.5	CHEMBL5334	Homo sapiens	Inhibition	%	2.5
	8218326	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.7	CHEMBL5334	Homo sapiens	Inhibition	%	4.7
	8218550	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	25.4	CHEMBL5334	Homo sapiens	Inhibition	%	25.4
	8218693	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	70.78	CHEMBL5334	Homo sapiens	Inhibition	%	70.78
	8219048	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	52.13	CHEMBL5334	Homo sapiens	Inhibition	%	52.13
	8219208	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.24	CHEMBL5334	Homo sapiens	Inhibition	%	0.24
	8219458	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.92	CHEMBL5334	Homo sapiens	Inhibition	%	1.92
	8219682	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.56	CHEMBL5334	Homo sapiens	Inhibition	%	5.56
	8219843	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.94	CHEMBL5334	Homo sapiens	Inhibition	%	0.94
	8220012	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.5	CHEMBL5334	Homo sapiens	Inhibition	%	1.5
	8220236	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.08	CHEMBL5334	Homo sapiens	Inhibition	%	1.08
	8220365	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	60.5	CHEMBL5334	Homo sapiens	Inhibition	%	60.5
	8220703	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	9.04	CHEMBL5334	Homo sapiens	Inhibition	%	9.04
	8220841	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	11.54	CHEMBL5334	Homo sapiens	Inhibition	%	11.54
	8221201	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.62	CHEMBL5334	Homo sapiens	Inhibition	%	1.62
	8221558	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.72	CHEMBL5334	Homo sapiens	Inhibition	%	8.72
	8221723	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.43	CHEMBL5334	Homo sapiens	Inhibition	%	3.43
	8222078	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	77.87	CHEMBL5334	Homo sapiens	Inhibition	%	77.87
	8222176	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.53	CHEMBL5334	Homo sapiens	Inhibition	%	0.53
	8222400	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	15.31	CHEMBL5334	Homo sapiens	Inhibition	%	15.31
	8222534	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	10.15	CHEMBL5334	Homo sapiens	Inhibition	%	10.15
	8222876	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	68.35	CHEMBL5334	Homo sapiens	Inhibition	%	68.35
	8223020	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	21.0	CHEMBL5334	Homo sapiens	Inhibition	%	21.0
	8223373	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.53	CHEMBL5334	Homo sapiens	Inhibition	%	4.53
	8223534	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.31	CHEMBL5334	Homo sapiens	Inhibition	%	-5.31
	8223758	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.7	CHEMBL5334	Homo sapiens	Inhibition	%	0.7
	8224008	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.94	CHEMBL5334	Homo sapiens	Inhibition	%	4.94
	8224170	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-4.86	CHEMBL5334	Homo sapiens	Inhibition	%	-4.86
	8224564	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-2.57	CHEMBL5334	Homo sapiens	Inhibition	%	-2.57
	8224699	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.71	CHEMBL5334	Homo sapiens	Inhibition	%	3.71
	8225037	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.45	CHEMBL5334	Homo sapiens	Inhibition	%	4.45
	8225171	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	45.25	CHEMBL5334	Homo sapiens	Inhibition	%	45.25
	8225395	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.11	CHEMBL5334	Homo sapiens	Inhibition	%	4.11
	8225533	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.64	CHEMBL5334	Homo sapiens	Inhibition	%	9.64
	8225892	CHEMBL1962181	GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	53.39	CHEMBL5334	Homo sapiens	Inhibition	%	53.39
	8226050	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.13	CHEMBL5334	Homo sapiens	Inhibition	%	-1.13
	8226399	CHEMBL1962180	GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.1	CHEMBL5334	Homo sapiens	Inhibition	%	5.1
	10838634	CHEMBL2014512	Inhibition of TNK1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	10.0	CHEMBL5334	Homo sapiens	INH	%	10.0
	10921408	CHEMBL2044937	Inhibition of TNK1 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	100.0	CHEMBL5334	Homo sapiens	INH	%	100.0
	10921409	CHEMBL2044938	Inhibition of TNK1 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	93.0	CHEMBL5334	Homo sapiens	INH	%	93.0
	12172176	CHEMBL2209255	Inhibition of TNK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5334	Homo sapiens	Activity	%	100.0
	12183799	CHEMBL2214462	Inhibition of TNK1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5334	Homo sapiens	pIC50		5.0
Not Active	13335964	CHEMBL2393927	Inhibition of TNK1 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Not Active	13335965	CHEMBL2393927	Inhibition of TNK1 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Not Active	13336014	CHEMBL2394056	Inhibition of TNK1 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Not Active	13336015	CHEMBL2394056	Inhibition of TNK1 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Not Active	13336016	CHEMBL2394056	Inhibition of TNK1 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
	13439737	CHEMBL2428862	Competitive binding affinity to TNK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	13442602	CHEMBL2428862	Competitive binding affinity to TNK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	81.0	CHEMBL5334	Homo sapiens	INH	%	81.0
	13445570	CHEMBL2428862	Competitive binding affinity to TNK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	13451557	CHEMBL2428862	Competitive binding affinity to TNK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
	15002473	CHEMBL3366587	Inhibition of TNK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	9.2	CHEMBL5334	Homo sapiens	Activity	%	9.2
	15667028	CHEMBL3603309	Inhibition of TNK1 (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	9.9	CHEMBL5334	Homo sapiens	Activity	%	9.9
	15756785	CHEMBL3631501	Inhibition of TNK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	89.03	CHEMBL5334	Homo sapiens	INH	%	89.03
	15757938	CHEMBL3631501	Inhibition of TNK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	95.2	CHEMBL5334	Homo sapiens	INH	%	95.2
	15758917	CHEMBL3631501	Inhibition of TNK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	22.51	CHEMBL5334	Homo sapiens	INH	%	22.51
	16432033	CHEMBL3750187	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5334	Homo sapiens	IC50	uM	10.0
Inactive	17945426	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945427	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	55.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	55.0
Active	17945428	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	6.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	6.0
Active	17945429	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	287.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	287.0
Inactive	17945430	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945431	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945432	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945433	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	5684.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	5684.0
Inactive	17945434	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945435	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	1778.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1778.0
Inactive	17945436	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945437	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945438	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945439	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945440	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945441	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	369.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	369.0
Inactive	17945442	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945443	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945444	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945445	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945446	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945447	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945448	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945449	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	1495.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1495.0
Inactive	17945450	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945451	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945452	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945453	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945454	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945455	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Kd	nM	1486.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1486.0
Active	17945456	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	39.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	39.0
Inactive	17945457	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945458	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	1661.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1661.0
Inactive	17945459	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945460	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945461	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945462	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945463	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945464	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945465	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945466	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945467	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	888.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	888.0
Inactive	17945468	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945469	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945470	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945471	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945472	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945473	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945474	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945475	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945476	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	1682.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1682.0
Inactive	17945477	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945478	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945479	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945480	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945481	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945482	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1683.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1683.0
Inactive	17945483	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945484	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	33.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	33.0
Inactive	17945485	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945486	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945487	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	1265.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1265.0
Inactive	17945488	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945489	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945490	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945491	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945492	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945493	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945494	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945495	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945496	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945497	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945498	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945499	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945500	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	66.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	66.0
Inactive	17945501	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945502	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945503	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945504	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945505	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945506	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945507	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	2653.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	2653.0
Inactive	17945508	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945509	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945510	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945511	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	678.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	678.0
Inactive	17945512	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945513	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945514	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945515	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945516	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945517	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945518	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945519	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945520	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945521	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945522	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945523	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945524	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945525	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	863.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	863.0
Active	17945526	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	27.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	27.0
Inactive	17945527	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945528	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945529	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945530	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945531	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945532	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945533	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945534	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945535	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945536	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945537	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945538	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945539	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945540	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945541	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945542	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945543	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945544	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945545	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945546	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945547	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945548	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945549	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945550	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945551	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945552	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945553	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	46.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	46.0
Active	17945554	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	3.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	3.0
Inactive	17945555	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945556	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945557	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945558	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945559	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945560	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945561	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945562	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945563	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	11269.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	11269.0
Inactive	17945564	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945565	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945566	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945567	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945568	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945569	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945570	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945571	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945572	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945573	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945574	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945575	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945576	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945577	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945578	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	108.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	108.0
Inactive	17945579	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945580	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	152.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	152.0
Inactive	17945581	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945582	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945583	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945584	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945585	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	160.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	160.0
Inactive	17945586	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945587	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945588	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945589	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945590	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945591	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945592	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	622.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	622.0
Inactive	17945593	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945594	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945595	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945596	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945597	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945598	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945599	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945600	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945601	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945602	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945603	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945604	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945605	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945606	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945607	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945608	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945609	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945610	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945611	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945612	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945613	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945614	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945615	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945616	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	536.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	536.0
Inactive	17945617	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945618	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945619	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945620	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945621	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945622	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945623	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945624	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945625	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945626	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945627	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945628	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945629	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945630	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945631	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945632	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945633	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945634	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945635	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945636	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945637	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945638	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945639	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945640	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	1270.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1270.0
Inactive	17945641	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945642	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945643	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	49.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	49.0
Inactive	17945644	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945645	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945646	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945647	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945648	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	558.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	558.0
Inactive	17945649	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945650	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1870.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1870.0
Inactive	17945651	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945652	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945653	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945654	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945655	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945656	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945657	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	=	Kd	nM	289.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	289.0
Inactive	17945658	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Active	17945659	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	1264.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	1264.0
Active	17945660	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	84.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	84.0
Inactive	17945661	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945662	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	173.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	173.0
Inactive	17945663	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945664	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945665	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945666	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945667	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945668	CHEMBL3991913	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5334	Homo sapiens	Kd apparent	nM	30000.0
	18064134	CHEMBL4013825	Inhibition of human TNK1 at 10 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	<	Inhibition	%	85.0	CHEMBL5334	Homo sapiens	INH	%	85.0
	18114886	CHEMBL4025416	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	92.0	CHEMBL5334	Homo sapiens	Activity	%	92.0
	18203940	CHEMBL4044227	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	93.0	CHEMBL5334	Homo sapiens	Activity	%	93.0
	18253267	CHEMBL4054917	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	34.0	CHEMBL5334	Homo sapiens	Activity	%	34.0
	18253268	CHEMBL4054917	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	92.0	CHEMBL5334	Homo sapiens	Activity	%	92.0
	18275322	CHEMBL4118486	Inhibition of TNK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SVPVAVKSLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	98.3	CHEMBL5334	Homo sapiens	INH	%	98.3
	18275323	CHEMBL4118486	Inhibition of TNK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SVPVAVKSLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	48.3	CHEMBL5334	Homo sapiens	INH	%	48.3
	18275324	CHEMBL4118486	Inhibition of TNK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SVPVAVKSLR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	13.9	CHEMBL5334	Homo sapiens	INH	%	13.9
Active	18276001	CHEMBL4118961	Binding affinity to TNK1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL5334	Homo sapiens	Activity		
	18440482	CHEMBL4157306	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	89.0	CHEMBL5334	Homo sapiens	Activity	%	89.0
	18484438	CHEMBL4186085	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL5334	Homo sapiens	Activity	%	89.0
	18484922	CHEMBL4186085	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	71.0	CHEMBL5334	Homo sapiens	Activity	%	71.0
	18653327	CHEMBL4230242	Inhibition of TNK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	84.0	CHEMBL5334	Homo sapiens	INH	%	84.0
	18653328	CHEMBL4230242	Inhibition of TNK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	19.0	CHEMBL5334	Homo sapiens	INH	%	19.0
	18655250	CHEMBL4230985	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	87.0	CHEMBL5334	Homo sapiens	Activity	%	87.0
	18752237	CHEMBL4264574	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	56.0	CHEMBL5334	Homo sapiens	Activity	%	56.0
	18858237	CHEMBL4308083	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	95.0	CHEMBL5334	Homo sapiens	Activity	%	95.0
	18919395	CHEMBL4322755	Binding affinity to recombinant human N-terminal GST-tagged TNK1 (106 to 390 residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	4.0	CHEMBL5334	Homo sapiens	Kd	nM	4.0
	18919583	CHEMBL4322755	Binding affinity to recombinant human N-terminal GST-tagged TNK1 (106 to 390 residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	13.0	CHEMBL5334	Homo sapiens	Kd	nM	13.0
	18938363	CHEMBL4327908	Inhibition of human TNK1 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.98	CHEMBL5334	Homo sapiens	Activity	%	99.98
	18938364	CHEMBL4327908	Inhibition of human TNK1 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	97.83	CHEMBL5334	Homo sapiens	Activity	%	97.83
	18938753	CHEMBL4328272	Inhibition of human TNK1 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5334	Homo sapiens	Activity	%	65.0
	18939140	CHEMBL4328636	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.584	CHEMBL5334	Homo sapiens	IC50	10'-10M	5.84
	18959009	CHEMBL4333665	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	70.0	CHEMBL5334	Homo sapiens	Activity	%	70.0
Active	19041310	CHEMBL4352571	Inhibition of human TNK1 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
	19059862	CHEMBL4358163	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	29.0	CHEMBL5334	Homo sapiens	Activity	%	29.0
	19090426	CHEMBL4366000	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	85.0	CHEMBL5334	Homo sapiens	Activity	%	85.0
	19092148	CHEMBL4366622	Inhibition of human TNK1 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.71	CHEMBL5334	Homo sapiens	INH	%	10.71
	19114515	CHEMBL4371405	Binding affinity to TNK1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	24.0	CHEMBL5334	Homo sapiens	Kd(free)	uM	0.024
	19114678	CHEMBL4371405	Binding affinity to TNK1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	14.0	CHEMBL5334	Homo sapiens	Kd(free)	uM	0.014
	19159690	CHEMBL4382794	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	3.3	CHEMBL5334	Homo sapiens	Activity	%	3.3
	19191317	CHEMBL4389513	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	65.0	CHEMBL5334	Homo sapiens	INH	%	65.0
	19192176	CHEMBL4389990	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	65.0	CHEMBL5334	Homo sapiens	INH	%	65.0
	19200432	CHEMBL4391616	Binding affinity to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	48.0	CHEMBL5334	Homo sapiens	Activity	%	48.0
	19266647	CHEMBL4405597	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5334	Homo sapiens	INH	%	50.0
Active	19271785	CHEMBL4406777	Inhibition of TNK1 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Active	19271786	CHEMBL4406777	Inhibition of TNK1 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
Active	19271787	CHEMBL4406777	Inhibition of TNK1 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717		Inhibition	%		CHEMBL5334	Homo sapiens	INH		
	19292302	CHEMBL4411553	Inhibition of N-terminal GST tagged human TNK1 (106 to 390 residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	94.0	CHEMBL5334	Homo sapiens	INH	%	94.0
	19292322	CHEMBL4411573	Inhibition of N-terminal GST tagged human TNK1 (106 to 390 residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of 1 mM ATP relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	64.0	CHEMBL5334	Homo sapiens	INH	%	64.0
	20669056	CHEMBL4620299	Inhibition of biotinylated ligand binding to wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL5334	Homo sapiens	INH	%	80.0
	20669681	CHEMBL4620452	Inhibition of TNK1 (unknown origin) in presence of 1 mM ATP relative to control	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F		CHEMBL4635625	=	Inhibition	%	50.6	CHEMBL5334	Homo sapiens	INH	%	50.6
	22423069	CHEMBL4674084	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5334	Homo sapiens	INH	%	80.0
	22423181	CHEMBL4674166	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	72.41	CHEMBL5334	Homo sapiens	Activity	%	72.41
	22423182	CHEMBL4674166	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	36.74	CHEMBL5334	Homo sapiens	Activity	%	36.74
	22843538	CHEMBL4720524	Inhibition of human TNK1 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.84	CHEMBL5334	Homo sapiens	IC50	10^-9M	1.84
	22843880	CHEMBL4720866	Inhibition of human TNK1 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	101.68	CHEMBL5334	Homo sapiens	Activity	%	101.68
	22844937	CHEMBL4721612	Inhibition of wild-type human full length TNK1 (M1 to P661 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	46.45	CHEMBL5334	Homo sapiens	Activity	%	46.45
	23122847	CHEMBL4805198	Inhibition of human TNK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	95.0	CHEMBL5334	Homo sapiens	Activity	%	95.0
	23123542	CHEMBL4805786	Inhibition of human TNK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	67.0	CHEMBL5334	Homo sapiens	Activity	%	67.0
	23123994	CHEMBL4806238	Inhibition of DNA-tagged human TNK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	98.0	CHEMBL5334	Homo sapiens	Activity	%	98.0
	23125174	CHEMBL4806803	Inhibition of human TNK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5334	Homo sapiens	Activity	%	100.0
	23125175	CHEMBL4806803	Inhibition of human TNK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5334	Homo sapiens	Activity	%	100.0
	23128653	CHEMBL4808026	Inhibition of TNK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL5334	Homo sapiens	Activity	%	50.0
	23128654	CHEMBL4808026	Inhibition of TNK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5334	Homo sapiens	Activity	%	75.0
	23128655	CHEMBL4808026	Inhibition of TNK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5334	Homo sapiens	Activity	%	75.0
	23128927	CHEMBL4808103	Inhibition of TNK1 (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	23.0	CHEMBL5334	Homo sapiens	INH	%	23.0
Not Active	23317683	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	66.0	CHEMBL5334	Homo sapiens	% Control	%	66.0
Not Active	23318151	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23318817	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	56.0	CHEMBL5334	Homo sapiens	% Control	%	56.0
Not Active	23319301	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23319937	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23320413	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23321091	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	59.0	CHEMBL5334	Homo sapiens	% Control	%	59.0
Not Active	23321559	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	84.0	CHEMBL5334	Homo sapiens	% Control	%	84.0
Not Active	23322189	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23322657	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL5334	Homo sapiens	% Control	%	93.0
Not Active	23323346	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23323814	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	97.0	CHEMBL5334	Homo sapiens	% Control	%	97.0
Not Active	23324668	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	65.0	CHEMBL5334	Homo sapiens	% Control	%	65.0
Not Active	23325303	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23325771	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23326418	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	74.0	CHEMBL5334	Homo sapiens	% Control	%	74.0
Not Active	23326886	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23327586	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23328054	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23328641	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	81.0	CHEMBL5334	Homo sapiens	% Control	%	81.0
Not Active	23329109	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23330055	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23330523	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23331279	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23331747	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23332334	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	87.6	CHEMBL5334	Homo sapiens	% Control	%	87.6
Not Active	23332800	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	95.0	CHEMBL5334	Homo sapiens	% Control	%	95.0
Not Active	23333518	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	62.1	CHEMBL5334	Homo sapiens	% Control	%	62.1
Not Active	23334157	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	64.0	CHEMBL5334	Homo sapiens	% Control	%	64.0
Not Active	23334625	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	85.0	CHEMBL5334	Homo sapiens	% Control	%	85.0
Not Active	23335604	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23336072	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23336699	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	94.0	CHEMBL5334	Homo sapiens	% Control	%	94.0
Not Active	23337167	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	66.0	CHEMBL5334	Homo sapiens	% Control	%	66.0
Not Active	23338248	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23338716	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	96.0	CHEMBL5334	Homo sapiens	% Control	%	96.0
Not Active	23339328	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	98.0	CHEMBL5334	Homo sapiens	% Control	%	98.0
Not Active	23339796	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23340433	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	80.0	CHEMBL5334	Homo sapiens	% Control	%	80.0
Not Active	23340901	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23341558	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	89.0	CHEMBL5334	Homo sapiens	% Control	%	89.0
Not Active	23342026	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	84.0	CHEMBL5334	Homo sapiens	% Control	%	84.0
Not Active	23342642	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23343110	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23343740	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23344208	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23344846	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	83.0	CHEMBL5334	Homo sapiens	% Control	%	83.0
Not Active	23345419	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23345887	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23346463	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23346932	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23347531	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	98.1	CHEMBL5334	Homo sapiens	% Control	%	98.1
Not Active	23348024	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	87.8	CHEMBL5334	Homo sapiens	% Control	%	87.8
Not Active	23348603	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23349071	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23349658	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	98.0	CHEMBL5334	Homo sapiens	% Control	%	98.0
Not Active	23350276	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23350744	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23351349	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	99.0	CHEMBL5334	Homo sapiens	% Control	%	99.0
Not Active	23351817	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	91.0	CHEMBL5334	Homo sapiens	% Control	%	91.0
Not Active	23352841	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	76.0	CHEMBL5334	Homo sapiens	% Control	%	76.0
Not Active	23353309	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	95.0	CHEMBL5334	Homo sapiens	% Control	%	95.0
Not Active	23354191	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23354659	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23355391	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23355859	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23356495	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23356963	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23357572	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23358219	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	98.0	CHEMBL5334	Homo sapiens	% Control	%	98.0
Not Active	23358687	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23359273	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23359871	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	77.0	CHEMBL5334	Homo sapiens	% Control	%	77.0
Not Active	23360339	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	94.0	CHEMBL5334	Homo sapiens	% Control	%	94.0
Not Active	23360924	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23361392	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23361965	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23362501	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	69.0	CHEMBL5334	Homo sapiens	% Control	%	69.0
Not Active	23362969	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	85.0	CHEMBL5334	Homo sapiens	% Control	%	85.0
Not Active	23364611	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	81.0	CHEMBL5334	Homo sapiens	% Control	%	81.0
Not Active	23365079	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	96.0	CHEMBL5334	Homo sapiens	% Control	%	96.0
Not Active	23365818	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	98.0	CHEMBL5334	Homo sapiens	% Control	%	98.0
Not Active	23366361	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	87.0	CHEMBL5334	Homo sapiens	% Control	%	87.0
Not Active	23366951	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	91.0	CHEMBL5334	Homo sapiens	% Control	%	91.0
Not Active	23367419	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23368297	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	97.0	CHEMBL5334	Homo sapiens	% Control	%	97.0
Not Active	23368765	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL5334	Homo sapiens	% Control	%	96.0
Not Active	23369364	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23369832	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	96.0	CHEMBL5334	Homo sapiens	% Control	%	96.0
Not Active	23370800	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23371268	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	76.0	CHEMBL5334	Homo sapiens	% Control	%	76.0
Not Active	23372077	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23372545	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	96.0	CHEMBL5334	Homo sapiens	% Control	%	96.0
	23372918	CHEMBL4884883	Tnk1(TNK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5334	Homo sapiens	pIC50		6.0
	23373327	CHEMBL4885174	Tnk1(TNK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5334	Homo sapiens	pIC50		6.0
	23373681	CHEMBL4885458	Tnk1(TNK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5334	Homo sapiens	pIC50		6.0
Not Active	23375972	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL5334	Homo sapiens	% Control	%	87.0
Not Active	23376440	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	56.0	CHEMBL5334	Homo sapiens	% Control	%	56.0
Not Active	23377017	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	59.0	CHEMBL5334	Homo sapiens	% Control	%	59.0
Not Active	23377485	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	55.0	CHEMBL5334	Homo sapiens	% Control	%	55.0
Not Active	23378345	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	86.0	CHEMBL5334	Homo sapiens	% Control	%	86.0
Not Active	23378813	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23379980	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	93.0	CHEMBL5334	Homo sapiens	% Control	%	93.0
Not Active	23380448	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	72.0	CHEMBL5334	Homo sapiens	% Control	%	72.0
Not Active	23381142	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23381790	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	88.0	CHEMBL5334	Homo sapiens	% Control	%	88.0
Not Active	23382258	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	93.0	CHEMBL5334	Homo sapiens	% Control	%	93.0
Not Active	23382882	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23383350	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	65.0	CHEMBL5334	Homo sapiens	% Control	%	65.0
Not Active	23383678	CHEMBL4887334	TNK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL5334	Homo sapiens	% Ctrl	%	92.0
Not Active	23385264	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5334	Homo sapiens	% Control	%	100.0
Not Active	23385732	CHEMBL4879989	KinomeScan assay: inhibition of TNK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL5334	Homo sapiens	% Control	%	87.0
